Navigation Links
Young, unvaccinated adults account for severest flu cases
Date:2/10/2014

DURHAM, N.C. A snapshot of patients who required care at Duke University Hospital during this year's flu season shows that those who had not been vaccinated had severe cases and needed the most intensive treatment.

In an analysis of the first 55 patients treated for flu at the academic medical center from November 2013 through Jan. 8, 2014, Duke Medicine researchers found that only two of the 22 patients who required intensive care had been vaccinated prior to getting sick.

The findings were published online in Monday, Feb. 10, 2014, in the American Journal of Respiratory and Critical Care Medicine.

"Our observations are important because they reinforce a growing body of evidence that the influenza vaccine provides protection from severe illness requiring hospitalizations," said lead author Cameron Wolfe, M.D., assistant professor of medicine at Duke. "The public health implications are important, because not only could a potentially deadly infection be avoided with a $30 shot, but costly hospitalizations could also be reduced."

Wolfe said this year's flu season was marked by hospitalizations of previously healthy young people, with a median age of 28.5 years. Among those who were hospitalized at Duke, 48 of the 55 were infected with the H1N1 virus that caused the 2009 pandemic. That outbreak also hit young adults particularly hard.

"We observed a high percentage of hospitalized patients for influenza requiring ICU level care, which appears higher than observed in our hospital during the 2009 pandemic flu season," said co-author John W. Hollingsworth, M.D., associate professor of medicine at Duke. "It remains unclear whether the high rate of ICU admissions represents a diagnosis bias or whether the severity of illness being caused by the current H1N1 virus is higher."

Of the 33 patients admitted to regular wards rather than the ICU at Duke University Hospital, only eleven had been vaccinated; most of those were immune compromised, chronically ill, or were on a medication that weakened the vaccine's protection.

The study also echoes other studies that have highlighted problems with a rapid test for influenza. Wolfe said 22 of the patients treated at Duke University Hospital had been given a rapid influenza test that came up negative for flu, but they were actually positive when tested by other methods. As a result, they had not received anti-viral medications that might have eased flu symptoms had they been taken early.

"Together, our observations during this influenza season support a high prevalence of the H1N1 virus affecting young adults and requiring ICU care, high false negative rates of rapid flu tests, and delay in starting antiviral treatment," Wolfe said. "Added to the finding of very low vaccination rates among both hospitalized and ICU admissions, our observations support previous findings that vaccination reduces the severity of disease and vaccinations should be encouraged as recommended by the U.S. Centers for Disease Control and Prevention."


'/>"/>

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center
Source:Eurekalert

Related biology news :

1. Perception of fertility affects quality of life in young, female cancer survivors
2. Thousands of unvaccinated adults die each year from preventable diseases
3. Nutritional supplement improves cognitive performance in older adults, study finds
4. Caring for animals may correlate with positive traits in young adults
5. T cell immunotherapy: Promising results in children and adults with leukemia
6. LSUHSC research finds inflammation linked to obesity in adults may be protective in young children
7. Natura Therapeutics product shown to improve decision making skills in older adults
8. Young adults with autism found to have difficulty transitioning into employment
9. Traffic pollution and wood smoke increases asthma in adults
10. Grape consumption associated with healthier eating patterns in US children and adults
11. Despite health benefits, most children and adults have a nutrition gap in omega-3 fatty acids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Minn. , Jan. 18, 2017 ... technology company that supports the entire spectrum of ... has been another record-breaking year for the organization ... market interest in MedNet,s eClinical products and services. ... the tremendous marketplace success of iMedNet ...
(Date:1/12/2017)... and PUNE, India , January 12, 2017 ... and Forecasts, 2015 - 2022," projects that the global biometric technology market is expected ... from 2016 to 2022. Continue Reading ... ... ...
(Date:1/6/2017)... , Jan. 5, 2017  SomaLogic announced today ... Life Alliance" established by iCarbonX, the ... build a "Global Digital Health Ecosystem that can ... combination of individual,s biological, behavioral and psychological data, ... between the companies, SomaLogic will provide proteomics data ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 /PRNewswire -- WuXi AppTec, ... open-access capability and technology platform, today announced that ... biology focused preclinical drug discovery contract research organization ... become a wholly-owned subsidiary of WuXi, and will ... and providing greater services. The acquisition will further ...
(Date:1/19/2017)... and GAITHERSBURG, Md. , Jan. ... and Altimmune, Inc., a privately-held immunotherapeutics company targeting ... definitive agreement for the merger of PharmAthene and ... include Novartis Venture Fund, HealthCap, Truffle Capital and ... fully-integrated and diversified immunotherapeutics company with four clinical ...
(Date:1/19/2017)... Ca (PRWEB) , ... January 18, 2017 , ... ... events for tech innovators, engineers, and scientists from around the world, was today ... News. The awards program is based entirely on merit and decided upon by ...
(Date:1/19/2017)... BETHESDA, Md. , Jan. 18, 2017  Northwest ... company developing DCVax® personalized immune therapies for operable and ... Marnix Bosch , Chief Technical Officer of NW Bio, ... Thursday, January 19, 2017, at the Hyatt Regency Hotel ... Dr. Bosch will chair the session entitled "New Therapeutic ...
Breaking Biology Technology: